CPRX
NASDAQ · Biotechnology
Catalyst Pharmaceuticals Inc
$31.49
+0.01 (+0.03%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+1.09%
1Y
+50.02%
YTD
+36.03%
Open$31.48
Previous Close$31.48
Day High$31.51
Day Low$31.48
52W High$32.56
52W Low$20.66
Volume—
Avg Volume3.49M
Market Cap3.85B
P/E Ratio17.42
EPS$1.74
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$28.16
Above
SMA 200
$23.83
Above
RSI (14)
65
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Sell
9 analysts
Price Target
+59.2% upside
Current
$31.49
$31.49
Target
$50.13
$50.13
$36.48
$50.13 avg
$69.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 566.58M | 404.41M | 680.16M |
| Net Income | 206.18M | 132.45M | -27,885,830 |
| Profit Margin | 36.4% | 34.6% | -4.1% |
| EBITDA | 284.05M | 192.61M | -33,860,903 |
| Free Cash Flow | — | — | -33,852,425 |
| Rev Growth | +40.1% | +40.1% | +20.9% |
| Debt/Equity | — | — | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |